Host-directed nanotherapy for the treatment and imaging of tuberculous meningitis
Theranostics · 2026
DOI: 10.7150/thno.125729 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Elizabeth W Tucker und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Hauptthemen laut MEDLINE: Tuberculosis, Meningeal, Theranostic Nanomedicine. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Rationale
Tuberculous meningitis (TB meningitis) is a devastating infection where the host immune response drives brain injury. Standard adjunctive corticosteroids often fail to prevent neurological sequelae or improve survival in many populations. Host-directed therapies that can cross the blood-brain barrier (BBB) and reduce neuroinflammation are urgently needed. We evaluated a hydroxyl-terminated polyamidoamine (PAMAM) dendrimer as a theranostic nanoplatform to visualize and treat microglia-mediated neuroinflammation in a young rabbit model of TB meningitis.
Methods
A novel radiolabeled dendrimer (124I-dendrimer) was synthesized for noninvasive positron emission tomography (PET) imaging, with post-mortem gamma counting and fluorescent-labeled dendrimer (D-Cy5) confirming biodistribution. For therapy, rabbits with TB meningitis (i.e., infected) received weekly intravenous dendrimer-N-acetyl cysteine (D-NAC) or phosphate buffered saline (PBS). After two weeks, treatment efficacy was evaluated with longitudinal neurobehavioral scores and multimodal PET (18F-FDG for glucose metabolism, 18F-py-albumin for BBB integrity, and 124I-DPA-713 for microglial/macrophage activation). Post-mortem analyses included bacterial burden (colony-forming units [CFU]), cerebrospinal fluid (CSF) protein and cytokine levels, and brain immunohistochemistry for glial and white matter markers.
Results
124I-Dendrimer demonstrated selective accumulation within brain lesions, co-localizing primarily with activated microglia. D-NAC significantly improved neurological outcomes and attenuated neuroinflammation and brain injury, even without antimicrobial therapy. Longitudinal PET imaging confirmed D-NAC efficacy, showing decreased neuroinflammation (124I-DPA-713) and improved BBB integrity (18F-py-albumin). Post-mortem analyses corroborated these findings, demonstrating that D-NAC reduced microglial inflammation and IL-17a levels, while improving myelination and BBB integrity.
Conclusions
This study establishes D-NAC as a promising host-directed theranostic strategy for TB meningitis and supports the clinical potential of dendrimer nanoplatforms to diagnose and treat central nervous system infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
- Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
- Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
- Center for Nanomedicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
- Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Förderung
- NIAID NIH HHS
Zitieren
APA
Tucker, E. W., Kim, J., Erice, C., Sharma, A., Damiba, N. N. L., Ordonez, A. A., Allende Labastida, J., Sah, N., Mota, F., de Jesus, P., Saini, R., Schiaffino, K. F., Jain, S. K., Kannan, R. M., & Kannan, S. (2026). Host-directed nanotherapy for the treatment and imaging of tuberculous meningitis. Theranostics. https://doi.org/10.7150/thno.125729
Vancouver
Tucker EW, Kim J, Erice C, Sharma A, Damiba NNL, Ordonez AA, et al. Host-directed nanotherapy for the treatment and imaging of tuberculous meningitis. Theranostics. 2026. doi:10.7150/thno.125729
BibTeX
@article{Tucker2026,
author = {Tucker, Elizabeth W and Kim, John and Erice, Clara and Sharma, Anjali and Damiba, Nerketa N L and Ordonez, Alvaro A and Allende Labastida, Javier and Sah, Nirnath and Mota, Filipa and de Jesus, Patricia and Saini, Rhea and Schiaffino, Kelly F and Jain, Sanjay K and Kannan, Rangaramanujam M and Kannan, Sujatha},
title = {Host-directed nanotherapy for the treatment and imaging of tuberculous meningitis},
journal = {Theranostics},
year = {2026},
doi = {10.7150/thno.125729}
}
EUVIMED